HBIO - Harvard Bioscience, Inc. Operating income before deduction of amortization
Harvard Bioscience is expanding its presence in the US and European biopharmaceutical sectors by supplying high-precision equipment. A stable staff of R&D engineers and the recruitment of top executives guarantee technological development. Current operating profit in cash demonstrates a trend where the metric value stands at 6.00. Profit growth is driven by global sales of unique, high-margin laboratory instruments.
Summary analytical data breakdowns for Harvard Bioscience (HBIO)
- stock quotes and analyst forecast:
- market capitalization statistics:
- balance sheet equity data:
- debt level and financial liquidity data:
Aggregate Debt to Capital Harvard Bioscience|HBIO - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital harvardbioscience.com|HBIO - Company Total Debt|Debts to Book Capitalization Harvard Bioscience|HBIO - Company Long-Term Debt|Company Current Liabilities Harvard Bioscience|Immediate Liquidity harvardbioscience.com
- earnings and valuation multiples indicators:
HBIO - Company Net Income|Net Profit Forecast Harvard Bioscience|HBIO - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Harvard Bioscience Inc.|HBIO - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Harvard Bioscience|HBIO - Operating profit EBITDA|Earnings per share for the trailing year Harvard Bioscience|HBIO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth harvardbioscience.com|HBIO - Earnings per share growth in current year|Expected earnings per share trend next year Harvard Bioscience
Fundamental company valuation:HBIO (Harvard Bioscience Inc.)
This indicator measures net cash flow from operating activities before depreciation and interest, allowing investors to assess the real efficiency of capital generation within the current credit environment. By analyzing the absolute cash result of operations, one can see how the diversification of precision component supplies at Harvard Bioscience (HBIO) minimizes assembly line downtime, transforming operational resilience into stable growth in marginal profitability.
Competitors of Harvard Bioscience (HBIO)
Income before deduction of interest, taxes and amortization ISRG|Danaher Corp. - Operating profit EBITDA|Operating income before deduction of amortization bd.com BDX|STERIS (STE) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WST|Profit before payment of interest, taxes and amortization Baxter Corp|Masimo Inc. (MASI) - Operating income before deduction of amortization|Operating profit before deduction of amortization STVN (Stevanato Group S.p.A.)|Company profit before taxes, interest and amortization TFX|Profit before payment of interest, taxes and amortization Merit Medical MMSI|Income before deduction of interest, taxes and amortization NVST|ICUI: Operating profit before deduction of amortization|XRAY - Operating profit EBITDA|LeMaitre Vascular, Inc. (LMAT) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization atricure.com|STAA (STAAR Surgical) - Operating profit EBITDA|Profit before interest, taxes and amortization ChromaDex Corp NAGE|Profit before payment of interest, taxes and amortization ZimVie Dental (ZIMV)|AngioDynamics Inc. - Operating profit before amortization|Cerus Corporation - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization TKNO (teknova.com)|MGRM - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Sharps Technology, Inc. STSS|INFU: Operating profit EBITDA|Utah Med - Income before deduction of interest, taxes and amortization|KRMD (KORU Medical Systems, Inc.) - Operating profit EBITDA|Operating profit EBITDA nyxoah.com|Profit before payment of interest, taxes and amortization Microbot Medical (MBOT)|PDEX (Pro-Dex Inc) - Income before deduction of interest, taxes and amortization|Zentek Limited - Operating profit before deduction of amortization|Elutia Corporation - Profit before payment of interest, taxes and amortization|Milestone Scientific - Operating profit EBITDA|NXGL - Operating profit EBITDA|retractable.com (RVP) - Profit before payment of interest, taxes and amortization|Femasys Inc - Income before deduction of interest, taxes and amortization|MHUA (Meihua Medical Technologies) - Operating profit EBITDA|Operating profit before amortization POAI (Predictive Oncology Corp)|Operating profit before deduction of amortization CJMB (Callan JMB Inc)|ATRI (atrioncorp.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NURO (NeuroMetrix)
